Verastem
VSTM

Verastem (VSTM) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BTIGMaintainedBuy$18.00Oct 8, 2026
BTIGMaintainedBuy$18.00Oct 5, 2026
HC Wainwright & Co.MaintainedBuy$18.00Oct 5, 2026
Wolfe ResearchInitiated CoverageOutperform—Sep 17, 2026
BTIGMaintainedBuy$18.00Sep 11, 2026
HC Wainwright & Co.MaintainedBuy$18.00Sep 11, 2026
MizuhoMaintainedOutperform$13.00 from $14.00Aug 11, 2026
GuggenheimMaintainedBuy$12.00 from $14.00Aug 7, 2026
RBC CapitalMaintainedOutperform$14.00 from $15.00Jul 7, 2026
BTIGMaintainedBuy$18.00Jul 2, 2026
BTIGMaintainedBuy$18.00Jun 24, 2026
HC Wainwright & Co.MaintainedBuy$18.00Jun 24, 2026
JefferiesMaintainedBuy$8.00 from $15.00Jun 23, 2026
MizuhoMaintainedOutperform$14.00 from $16.00May 14, 2026
BTIGMaintainedBuy$18.00 from $19.00May 8, 2026
BTIGMaintainedBuy$19.00Apr 23, 2026
BTIGMaintainedBuy$19.00Apr 20, 2026
HC Wainwright & Co.MaintainedBuy$18.00Apr 10, 2026
BTIGMaintainedBuy$19.00Apr 10, 2026
JefferiesInitiated CoverageBuy$15.00 from $19.00Mar 30, 2026

Frequently asked questions

  • What is the latest analyst rating on VSTM?

    On Oct 8, 2026, BTIG maintained Verastem at Buy with a price target of $18.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.